BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Eksigent Technologies Announces Major Expansion for HPLC Manufacturing and Service


7/22/2009 11:24:40 AM

Dublin, CA, July 21, 2009 - Eksigent Technologies, a leading provider of advanced low-flow fluid delivery technologies for drug discovery and other life science applications, today announced that it will increase manufacturing capacity by 40 percent to meet strong demand for its HPLC products.

"The need for this increase in product build capability is being driven by higher than expected customer demand for both our cHiPLC®-nanoflex for proteomics, introduced in February of this year, and our ExpressHT-Ultra HPLC System for ADME-Tox and DMPK studies, introduced last fall," stated David Neyer, vice president and co-founder of Eksigent. "We are also actively recruiting for field service personnel to ensure that customer installations are maintained at our traditionally short lead times."

Eksigent's Board of Directors approved spending last month for additional equipment, tools and staff. "Fortunately, the plant space was available to immediately accommodate this expansion, which will be complete next month," said Wade Guindy, Eksigent vice president of R&D, engineering and operations.

The new cHiPLC-nanoflex System is a docking station for up to three microfluidic chips that contain nanoLC or trap columns. The system delivers improved reproducibility and ease of use to proteomics research. The ExpressHT-Ultra HPLC system is the latest offering in Eksigent's line of products for small molecule analysis. It provides short cycle times and high throughput for LC/MS studies of pharmacokinetics and drug metabolism.

Eksigent serves the life science, drug discovery and pharmaceutical industries, expanding customer possibilities with low-flow fluid delivery solutions. From precise separation of precious samples in proteomics research to fast and efficient analytical chromatography to unique medical devices that improve the way drugs are delivered, Eksigent brings novel solutions to customer challenges. The company combines proprietary microfluidic pumping technology with creative approaches that help customers improve productivity and expand their research and market opportunities. Eksigent serves customers throughout the world, including Europe, Asia and Australia, through a growing sales and service network. For more information, visit http://www.eksigent.com.

Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->